Home intravenous antibiotic therapy: new technologies.

摘要: Over the past 15 years, an increasing variety of intravenous (IV) therapies have been administered to patients both at home and in outpatient setting. Intravenous anti-infective chemotherapeutic agents, analgesics, blood product coagulation factor replacement, immunoglobulins, even positive inotropic drugs [12] safely effectively home. All these therapeutic modalities share a number characteristics including need for integrated team approach (physicians, pharmacists, nurses), careful inclusion exclusion criteria, structured follow up process, increased responsibility on patient’s part self-care. [17] In United States, interest in, availability of, care infusion services (both hospital- home-based), new venous access devices, emphasis economic aspects health provision, development technologies, enabled more be appropriately conveniently treated with or IV antibiotics. most instances, either patient someone (parent, spouse, other support person) administers drug. Europe, potential barriers implementation antibiotic include such issues as who may legally administer drugs, trained staff, financial reimbursement services. Structural legal differ between countries.